Matt Zuga Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Matt Zuga is CFO & Chief Business Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 211,445 shares of ABOS, which is worth approximately $640,678. The most recent transaction as insider was on Jan 18, 2024, when has been sold 4,242 shares (Common Stock) at a price of $3.7 per share, resulting in proceeds of $15,695. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K
0% 3M change
92.77% 12M change
Total Value Held $640,678

Matt Zuga Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 18 2024
SELL
Open market or private sale
$15,695 $3.7 p/Share
4,242 Reduced 1.97%
211,445 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
106,000 Added 32.95%
215,687 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
33,500 Added 23.4%
109,687 Common Stock
Dec 29 2022
BUY
Exercise of conversion of derivative security
$59,500 $1.19 p/Share
50,000 Added 39.62%
76,187 Common Stock
Jul 06 2021
BUY
Conversion of derivative security
-
26,187 Added 50.0%
26,187 Common Stock

Also insider at

AZYO
AZIYO BIOLOGICS, INC. Healthcare
MZ

Matt Zuga

CFO & Chief Business Officer
Charlottesville, VA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS